Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: Association with blood-brain barrier damage and neurological sequelae
D. Leppert et al., Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: Association with blood-brain barrier damage and neurological sequelae, CLIN INF D, 31(1), 2000, pp. 80
To evaluate the spectrum and regulation of matrix metalloproteinases (MMPs)
in bacterial meningitis (BM), concentrations of MMP-2, MMP-3, MMP-8, and M
MP-8 and endogenous inhibitors of metalloproteinases (TIMP-1 and TIMP-2) we
re measured in the cerebrospinal fluid (CSF) of 27 children with BM. MMP-8
and MMP-9 were detected in 91% and 97%, respectively, of CSF specimens from
patients but were not detected in control patients. CSF levels of MMP-9 we
re higher (P < .05) in 5 patients who developed hearing impairment or secon
dary epilepsy than in those who recovered without neurological deficits. Le
vels of MMP-9 correlated with concentrations of TIMP-1 (P < .001) and tumor
necrosis factor-ac (P = .03), Repeated lumbar punctures showed that levels
of MMP-8 and MMP-9 were regulated independently and did not correlate with
the CSF cell count. Therefore, MMPs may derive not only from granulocytes
infiltrating the CSF space but also from parenchymal cells of the meninges
and brain. High concentrations of MMP-9 are a risk factor for the developme
nt of postmeningitidal neurological sequelae.